Inventor · disambiguated record
Xiumei Lin
Also filed as: LIN XIUMEI
8 granted patents·2 pending applications·4 citations·filing 2016–2022
74Inventor score
Top patents by PatentIndex Score
10 records- 0187US11466053B2Polypeptide and use thereofBGI SHENZHEN·Filed 2019·Granted Oct 11, 2022·4 cites·15 claims
- 0266US11834516B2Tumor-specific polypeptide and use thereofGENOIMMUNE THERAPEUTICS CO LTD·Filed 2021·Granted Dec 5, 2023·0 cites·6 claims
- 0362US11396528B2Polypeptide and use thereofBGI SHENZHEN·Filed 2019·Granted Jul 26, 2022·0 cites·14 claims
- 0460US11142547B2Polypeptide and use thereofGENOIMMUNE THERAPEUTICS CO LTD·Filed 2019·Granted Oct 12, 2021·0 cites·9 claims
- 0556US11213563B2Polypeptide and use thereofGENOIMMUNE THERAPEUTICS CO LTD·Filed 2019·Granted Jan 4, 2022·0 cites·15 claims
- 0653US11161874B2Tumor-specific polypeptide and use thereofGENOIMMUNE THERAPEUTICS CO LTD·Filed 2016·Granted Nov 2, 2021·0 cites·2 claims
- 0750US11612643B2Col14A1-derived tumor antigen polypeptide and use thereofGENOIMMUNE THERAPEUTICS CO LTD·Filed 2016·Granted Mar 28, 2023·0 cites·8 claims
- 0846US2024200057A1Method for Constructing RNA Sequencing Library, Sequencing Method and KitBGI SHENZHEN·Filed 2021·Application pending·0 cites
- 0946US2025154495A1Construction Method and Sequencing Method for Single-Cell Transcriptome Sequencing Library and Kit for Preparing Single-Cell Transcriptome LibraryBGI SHENZHEN·Filed 2022·Application pending·0 cites
- 1042US11548925B2CACNA1H-derived tumor antigen polypeptide and use thereofGENOIMMUNE THERAPEUTICS CO LTD·Filed 2016·Granted Jan 10, 2023·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Xiumei Lin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →